Collectively, these studies indicate that IL-38 expression and function under inflammatory conditions reflect a regulatory loop that limits inflammation, including conditions associated with exacerbated trained immunity, but may also lead to detrimental immune suppression, which affects immune defenses during infection or cancer. This evidence concerns the gene IL1F10 and cancer.